In vitro activity and disk susceptibility of timentin: current status
- 1 November 1985
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (5) , 25-32
- https://doi.org/10.1016/0002-9343(85)90125-1
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolatesAntimicrobial Agents and Chemotherapy, 1984
- Susceptibility of gram-negative bacteria andStaphylococcus aureus to combinations of ticarcillin and clavulanic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limitsAntimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acidAntimicrobial Agents and Chemotherapy, 1983
- Synergistic activity of piperacillin in combination with beta-lactamase inhibitorsAntimicrobial Agents and Chemotherapy, 1980
- In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillinJournal of Antimicrobial Chemotherapy, 1980
- Clavulanic acid and CP-45, 899: a comparison of their in vitro activity in combination with penicillinsJournal of Antimicrobial Chemotherapy, 1980
- In vitro antimicrobial activity of piperacillin and seven other β-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including β-lactamase producing strainsJournal of Antimicrobial Chemotherapy, 1979
- Combined Activity of Clavulanic Acid and Ticarcillin Against Ticarcillin-Resistant, Gram-Negative BacilliAntimicrobial Agents and Chemotherapy, 1978